Ginette Santiago-Sanchez

5PUBLICATIONS
17CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jul 01, 2026
PARP inhibition combined with a T-cell receptor β chain-directed antibody fusion molecule drives polyclonal antitumor immunity and tumor regression.

|Feb 02, 2024
A landscape of checkpoint blockade resistance in cancer: underlying mechanisms and current strategies to overcome resistance.

Ginette S Santiago-Sánchez, Kellsye P Fabian, James W Hodge

|May 11, 2023
Exploiting docetaxel-induced tumor cell necrosis with tumor targeted delivery of IL-12.

S Elizabeth Franks, Ginette S Santiago-Sanchez, Kellsye P Fabian

|Oct 10, 2022
Immune targeting of three independent suppressive pathways (TIGIT, PD-L1, TGFβ) provides significant antitumor efficacy in immune checkpoint resistant models.

S Elizabeth Franks, Kellsye P Fabian, Ginette Santiago-Sánchez

|Jan 11, 2022
Reduced RBPMS Levels Promote Cell Proliferation and Decrease Cisplatin Sensitivity in Ovarian Cancer Cells.

Robert J Rabelo-Fernández, Ginette S Santiago-Sánchez, Rohit K Sharma

Pageof 1

Frequent Collaborators

4 joint publications

Kellsye P Fabian

4 joint publications

James W Hodge

2 joint publications

S Elizabeth Franks

1 joint publications

Robert J Rabelo-Fernández